Literature DB >> 20110414

Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species.

Jenean O'Brien1, Traci Lyons, Jenifer Monks, M Scott Lucia, R Storey Wilson, Lisa Hines, Yan-gao Man, Virginia Borges, Pepper Schedin.   

Abstract

Recent pregnancy correlates with decreased survival for breast cancer patients compared with non-pregnancy-associated breast cancer. We hypothesize that postpartum mammary involution induces metastasis through wound-healing programs known to promote cancer. It is unknown whether alternatively activated M2 macrophages, immune cells important in wound-healing and experimental tumorigenesis that also predict poor prognosis for breast cancer patients, are recruited to the normal involuting gland. Macrophage markers CD68, CSF-1R, and F4/80 were examined across the pregnancy and involution cycle in rodent and human mammary tissues. Quantitative immunohistochemistry revealed up to an eightfold increase in macrophage number during involution, which returned to nulliparous levels with full regression. The involution macrophages exhibit an M2 phenotype as determined by high arginase-1 and low inducible nitric oxide synthase staining in rodent tissue, and by mannose receptor expression in human breast tissue. M2 cytokines IL-4 and IL-13 also peaked during involution. Extracellular matrix (ECM) isolated from involuting rat mammary glands was chemotactic for macrophages compared with nulliparous mammary ECM. Fibrillar collagen levels and proteolysis increased dramatically during involution, and denatured collagen I acted as a strong chemoattractant for macrophages in cell culture, suggesting proteolyzed fibrillar collagen as a candidate ECM mediator of macrophage recruitment. M2 macrophages, IL-4, IL-13, fibrillar collagen accumulation, and proteolysis of collagen are all components of tumor promotional microenvironments, and thus may mediate promotion of breast cancers arising in the postpartum setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110414      PMCID: PMC2832146          DOI: 10.2353/ajpath.2010.090735

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  103 in total

1.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

Authors:  Elaine Y Lin; Jiu-Feng Li; Leoid Gnatovskiy; Yan Deng; Liyin Zhu; Dustin A Grzesik; Hong Qian; Xiao-nan Xue; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2006-11-17       Impact factor: 12.701

Review 2.  Post-lactational mammary gland regression: molecular basis and implications for breast cancer.

Authors:  Christine J Watson
Journal:  Expert Rev Mol Med       Date:  2006-12-20       Impact factor: 5.600

Review 3.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo.

Authors:  Jeffrey B Wyckoff; Sophie E Pinner; Steve Gschmeissner; John S Condeelis; Erik Sahai
Journal:  Curr Biol       Date:  2006-08-08       Impact factor: 10.834

5.  Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland.

Authors:  Wendy V Ingman; Jeff Wyckoff; Valerie Gouon-Evans; John Condeelis; Jeffrey W Pollard
Journal:  Dev Dyn       Date:  2006-12       Impact factor: 3.780

Review 6.  Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Authors:  Akira Orimo; Robert A Weinberg
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

7.  Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment.

Authors:  Gao Guo; Patrick Booms; Marc Halushka; Harry C Dietz; Andreas Ney; Sigmar Stricker; Jochen Hecht; Stefan Mundlos; Peter N Robinson
Journal:  Circulation       Date:  2006-10-09       Impact factor: 29.690

Review 8.  Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion.

Authors:  Jo A Van Ginderachter; Kiavash Movahedi; Gholamreza Hassanzadeh Ghassabeh; Sofie Meerschaut; Alain Beschin; Geert Raes; Patrick De Baetselier
Journal:  Immunobiology       Date:  2006-07-21       Impact factor: 3.144

9.  Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women.

Authors:  Martha L Slattery; Carol Sweeney; Sandra Edwards; Jennifer Herrick; Kathy Baumgartner; Roger Wolff; Maureen Murtaugh; Richard Baumgartner; Anna Giuliano; Tim Byers
Journal:  Breast Cancer Res Treat       Date:  2007-03       Impact factor: 4.872

Review 10.  Microenvironment of the involuting mammary gland mediates mammary cancer progression.

Authors:  Pepper Schedin; Jenean O'Brien; Michael Rudolph; Torsten Stein; Virginia Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

View more
  137 in total

Review 1.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

2.  Emerging targets for the prevention of pregnancy-associated breast cancer.

Authors:  Jaime Fornetti; Holly Martinson; Virginia Borges; Pepper Schedin
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

Review 3.  Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.

Authors:  Ori Maller; Holly Martinson; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-02       Impact factor: 2.673

Review 4.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 5.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

6.  Mucosal Immunity in the Female Murine Mammary Gland.

Authors:  Courtney B Betts; Nathan D Pennock; Breanna P Caruso; Brian Ruffell; Virginia F Borges; Pepper Schedin
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

Review 7.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

Review 8.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

9.  Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets.

Authors:  Kara J Mould; Nathan D Jackson; Peter M Henson; Max Seibold; William J Janssen
Journal:  JCI Insight       Date:  2019-03-07

10.  Reducing interferon'ce in stem cells.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Nat Cell Biol       Date:  2017-05-31       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.